SCHEMBL23937643

SCHEMBL23937643

Cc1cn(O)c2c1CCC2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
RAB9A P51151 6/20 0.32
LMNA P02545 5/20 0.32
HTT P42858 4/20 0.32
SMN1; SMN2 Q16637 4/20 0.32
NR2F2 P24468 2/20 0.32
NPC1 O15118 3/20 0.30
S1PR2 O95136 2/20 0.30
NPSR1 Q6W5P4 2/20 0.30
SLC2A1 P11166 2/20 0.30
MEN1 O00255 1/20 0.30
CYP1A2 P05177 1/20 0.30
POLB P06746 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
MAPT P10636 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
KMT2A Q03164 1/20 0.30
NLRP3 Q96P20 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23937907 0.95 ALOX5 (0.33) KDM4ERAB9ANPC1KMT2AALDH1A1
SCHEMBL23937908 0.93 ALOX5 (0.35) KDM4E
SCHEMBL24701731 0.74 RAB9A (0.36) KDM4ERAB9ALMNAHTTSMN1; SMN2
SCHEMBL20631139 0.72 RAB9A (0.36) KDM4ERAB9ALMNAHTTSMN1; SMN2
SCHEMBL20631142 0.72 KDM4E (0.33) KDM4EALDH1A1
SCHEMBL20631118 0.71 CA2 (0.32) KDM4ELMNANPSR1CYP1A2CYP2C9
SCHEMBL20631153 0.71 CNR2 (0.35) KDM4ELMNAHTTNPC1MEN1
SCHEMBL14788205 0.70 RAB9A (0.33) KDM4ERAB9ALMNAHTTSMN1; SMN2
SCHEMBL20631138 0.70 GRIA2 (0.35) KDM4ERAB9ANPC1MEN1CYP1A2
SCHEMBL20631115 0.69 PTGS2 (0.35) KDM4ECYP1A2CYP2D6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed